Hope Rises for Safety Law
Pharmacists and patient groups welcome the new European Union directive on pharmacovigilance.
Pain Drugs: A Diverse Field
Updates on the pian drugs market.
Improve the Business of Science
Collecting too many metrics can lead to misappropriation and misinterpretation.
Business and News Update October 2010
Industry news focusing on the people and organizations who work in the clinical trials profession.
Act cover
S
Conducting Clinical Trials Beyond Europe
Routine inspections and regulations can help maintain GCP standards in global trials.
Sponsors Cope with New Sunshine Act Rules
Reform law requires tracking and disclosure of fees to investigators and research consultants.
A Learning Health Care System: One Giant Leap
Access to all available medical evidence can profoundly improve treatment effectiveness.
Clinical Grants Expenditures are on the Rise Throughout the World
Clinical grant expenditures represent a major portion of the budget for later phase clinical trials.
Waive Inclusion and Exclusion Criteria?
Waiving inclusion/exclusion criteria affects investigators, subjects, sponsors, and the trial itself.
Implications of Physician Payment Act
The act creates serious concerns about the industry's ability to recruit and retain well-qualified investigators.
Is It Safe to Outsource Safety?
Knowing when to outsource and when to conduct pharmacovigilance in-house is a crucial decision.
